Pages that link to "Q51022920"
Jump to navigation
Jump to search
The following pages link to Expansion of human Valpha24 NKT cells by repeated stimulation with KRN7000. (Q51022920):
Displaying 43 items.
- Invariant NKT cells as novel targets for immunotherapy in solid tumors (Q21284987) (← links)
- Immunoregulation of NKT Cells in Systemic Lupus Erythematosus (Q26773074) (← links)
- EBV promotes human CD8 NKT cell development (Q27314724) (← links)
- Glycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T Cells (Q27676395) (← links)
- Production of α-galactosylceramide by a prominent member of the human gut microbiota (Q28534671) (← links)
- Runt-related transcription factor 3 is involved in the altered phenotype and function in ThPok-deficient invariant natural killer T cells (Q33858298) (← links)
- Differential antitumor immunity mediated by NKT cell subsets in vivo (Q34603019) (← links)
- Potential role of IL-17-producing iNKT cells in type 1 diabetes (Q35161591) (← links)
- Invariant NKT cells are required for airway inflammation induced by environmental antigens (Q35213600) (← links)
- Type 1 diabetes and NKT cells: a report on the 3rd International Workshop on NKT cells and CD1-mediated antigen presentation, September 2004, Heron Island, QLD, Australia (Q35612660) (← links)
- Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal model (Q35670019) (← links)
- Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation (Q35837120) (← links)
- Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans (Q35850754) (← links)
- Valpha14 NKT cell-mediated anti-tumor responses and their clinical application (Q36009625) (← links)
- Engineering lymphocyte subsets: tools, trials and tribulations (Q36140986) (← links)
- Regulation of immunity by self-reactive T cells (Q36148406) (← links)
- Invariant NKT cells increase drug-induced osteosarcoma cell death (Q36446525) (← links)
- Natural killer T cell-mediated antitumor immune responses and their clinical applications (Q36521991) (← links)
- Natural killer T cells and haemopoiesis (Q36539582) (← links)
- Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation (Q36835483) (← links)
- NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi (Q37018981) (← links)
- Clinical applications of natural killer T cell-based immunotherapy for cancer (Q37092313) (← links)
- Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms (Q37246757) (← links)
- Clinical application of NKT cell biology in type I (autoimmune) diabetes mellitus. (Q37395299) (← links)
- Human invariant natural killer T cells: implications for immunotherapy (Q37565143) (← links)
- Invariant natural killer T cell-based immunotherapy for cancer (Q37773278) (← links)
- Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells (Q38028844) (← links)
- Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy (Q38435415) (← links)
- Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy (Q38666579) (← links)
- Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression. (Q38734173) (← links)
- Cancer immunotherapy. (Q39958332) (← links)
- A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production (Q40832140) (← links)
- Subpopulations of natural killer-T-like cells before and after surgical treatment of laryngeal cancer. (Q47134083) (← links)
- Isolation and Functional Use of Human NKT Cells (Q47578808) (← links)
- Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide. (Q53660956) (← links)
- Differential Role of Cathepsins S and B In Hepatic APC-Mediated NKT Cell Activation and Cytokine Secretion. (Q55117842) (← links)
- The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma (Q58788254) (← links)
- Limited correlation between human thymus and blood NKT?cell content revealed by an ontogeny study of paired tissue samples (Q60489505) (← links)
- Expansion of Valpha24( )Vbeta11( ) NKT cells from cord blood mononuclear cells using IL-15, IL-7 and Flt3-L depends on monocytes (Q82100046) (← links)
- A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings (Q83680959) (← links)
- Natural killer T cells are essential for the development of contact hypersensitivity in BALB/c mice (Q87732051) (← links)
- SLAM-SAP-Fyn: Old Players with New Roles in iNKT Cell Development and Function (Q90383325) (← links)
- The peripheral differentiation of human natural killer T cells (Q92387413) (← links)